Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Investigating the effects of lycopene and green tea on the metabolome of men at risk of prostate cancer: The ProDiet randomised controlled trial.

Beynon RA, Richmond RC, Santos Ferreira DL, Ness AR, May M, Smith GD, Vincent EE, Adams C, Ala-Korpela M, Würtz P, Soidinsalo S, Metcalfe C, Donovan JL, Lane AJ, Martin RM; ProtecT Study Group; PRACTICAL consortium.

Int J Cancer. 2019 Apr 15;144(8):1918-1928. doi: 10.1002/ijc.31929. Epub 2018 Dec 7.

PMID:
30325021
2.

ProDiet: A Phase II Randomized Placebo-controlled Trial of Green Tea Catechins and Lycopene in Men at Increased Risk of Prostate Cancer.

Lane JA, Er V, Avery KNL, Horwood J, Cantwell M, Caro GP, Crozier A, Smith GD, Donovan JL, Down L, Hamdy FC, Gillatt D, Holly J, Macefield R, Moody H, Neal DE, Walsh E, Martin RM, Metcalfe C.

Cancer Prev Res (Phila). 2018 Nov;11(11):687-696. doi: 10.1158/1940-6207.CAPR-18-0147. Epub 2018 Oct 11.

PMID:
30309839
3.

Effect of green tea and lycopene on the insulin-like growth factor system: the ProDiet randomized controlled trial.

Biernacka KM, Holly JMP, Martin RM, Frankow A, Bull CJ, Hamdy FC, Donovan JL, Neal DE, Metcalfe C, Lane A.

Eur J Cancer Prev. 2019 Mar 27. doi: 10.1097/CEJ.0000000000000502. [Epub ahead of print]

PMID:
30921005
4.

Men's knowledge and attitudes towards dietary prevention of a prostate cancer diagnosis: a qualitative study.

Horwood JP, Avery KN, Metcalfe C, Donovan JL, Hamdy FC, Neal DE, Lane JA.

BMC Cancer. 2014 Nov 5;14:812. doi: 10.1186/1471-2407-14-812.

5.

Tea and lycopene protect against prostate cancer.

Jian L, Lee AH, Binns CW.

Asia Pac J Clin Nutr. 2007;16 Suppl 1:453-7.

6.

Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.

Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, Stampfer MJ.

Cancer Res. 1999 Mar 15;59(6):1225-30.

7.

A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk.

Bunker CH, McDonald AC, Evans RW, de la Rosa N, Boumosleh JM, Patrick AL.

Nutr Cancer. 2007;57(2):130-7.

PMID:
17571945
8.

Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA.

Paur I, Lilleby W, Bøhn SK, Hulander E, Klein W, Vlatkovic L, Axcrona K, Bolstad N, Bjøro T, Laake P, Taskén KA, Svindland A, Eri LM, Brennhovd B, Carlsen MH, Fosså SD, Smeland SS, Karlsen AS, Blomhoff R.

Clin Nutr. 2017 Jun;36(3):672-679. doi: 10.1016/j.clnu.2016.06.014. Epub 2016 Jun 30.

9.

Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Kristal AR, Till C, Platz EA, Song X, King IB, Neuhouser ML, Ambrosone CB, Thompson IM.

Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):638-46. doi: 10.1158/1055-9965.EPI-10-1221. Epub 2011 Feb 18.

10.

A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?

Gontero P, Marra G, Soria F, Oderda M, Zitella A, Baratta F, Chiorino G, Gregnanin I, Daniele L, Cattel L, Frea B, Brusa P.

Prostate. 2015 Aug 1;75(11):1177-86. doi: 10.1002/pros.22999. Epub 2015 Apr 20.

PMID:
25893930
11.

Phytotherapeutic interventions in the management of biochemically recurrent prostate cancer: a systematic review of randomised trials.

van Die MD, Bone KM, Emery J, Williams SG, Pirotta MV, Paller CJ.

BJU Int. 2016 Apr;117 Suppl 4:17-34. doi: 10.1111/bju.13361. Epub 2016 Feb 22. Review.

12.

Prostate cancer - evidence of exercise and nutrition trial (PrEvENT): study protocol for a randomised controlled feasibility trial.

Hackshaw-McGeagh L, Lane JA, Persad R, Gillatt D, Holly JM, Koupparis A, Rowe E, Johnston L, Cloete J, Shiridzinomwa C, Abrams P, Penfold CM, Bahl A, Oxley J, Perks CM, Martin R.

Trials. 2016 Mar 7;17(1):123. doi: 10.1186/s13063-016-1248-x.

13.

Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation.

Magbanua MJ, Roy R, Sosa EV, Weinberg V, Federman S, Mattie MD, Hughes-Fulford M, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM.

PLoS One. 2011;6(9):e24004. doi: 10.1371/journal.pone.0024004. Epub 2011 Sep 1.

14.

Lycopene for the prevention of prostate cancer.

Ilic D, Forbes KM, Hassed C.

Cochrane Database Syst Rev. 2011 Nov 9;(11):CD008007. doi: 10.1002/14651858.CD008007.pub2. Review.

PMID:
22071840
15.

Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy.

Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, Khachik F, Li YW, Banerjee M, Grignon D, Bertram JS, Crissman JD, Pontes EJ, Wood DP Jr.

Cancer Epidemiol Biomarkers Prev. 2001 Aug;10(8):861-8.

16.

Effects of lycopene supplementation in patients with localized prostate cancer.

Kucuk O, Sarkar FH, Djuric Z, Sakr W, Pollak MN, Khachik F, Banerjee M, Bertram JS, Wood DP Jr.

Exp Biol Med (Maywood). 2002 Nov;227(10):881-5.

PMID:
12424329
17.

Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention.

Chen L, Stacewicz-Sapuntzakis M, Duncan C, Sharifi R, Ghosh L, van Breemen R, Ashton D, Bowen PE.

J Natl Cancer Inst. 2001 Dec 19;93(24):1872-9.

PMID:
11752012
18.

Results of a Randomized Clinical Trial of the Action of Several Doses of Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy.

Kumar NB, Besterman-Dahan K, Kang L, Pow-Sang J, Xu P, Allen K, Riccardi D, Krischer JP.

Clin Med Urol. 2008 Apr 16;1:1-14.

19.

Lycopene and soy isoflavones in the treatment of prostate cancer.

Vaishampayan U, Hussain M, Banerjee M, Seren S, Sarkar FH, Fontana J, Forman JD, Cher ML, Powell I, Pontes JE, Kucuk O.

Nutr Cancer. 2007;59(1):1-7.

PMID:
17927495
20.

Lycopene inhibits disease progression in patients with benign prostate hyperplasia.

Schwarz S, Obermüller-Jevic UC, Hellmis E, Koch W, Jacobi G, Biesalski HK.

J Nutr. 2008 Jan;138(1):49-53.

PMID:
18156403

Supplemental Content

Support Center